General Investing >> Money Manager Interviews >> April 30, 2013
Investing in Health Care Innovation
Finny Kuruvilla, M.D., Ph.D., serves as the Portfolio Manager of the Eventide Gilead Fund. Under his leadership, the Eventide Gilead Fund was ranked, according to Morningstar, to be in the top one percentile of all midcap growth mutual funds, out of 680 funds, for the three-year period ending July 1, 2011. In addition, the fund has garnered numerous awards from The Wall Street Journal for its outperformance since inception in July 2008. Dr. Kuruvilla has a unique background in health care, statistics and investing. Since 2008, Dr. Kuruvilla has been a Principal at Clarus Ventures, a health care venture capital firm with $1.2 billion under management. Prior to Clarus, he did quantitative algorithm development at MIT in the area of pseudo-Bayesian expectation maximization and logistic regression. He received his M.D. from Harvard Medical School, his Ph.D. from Harvard University, his master's degree from MIT and his bachelor's degree from Caltech. Profile
TWST: Before we discuss your health care-related fund more specifically, would you introduce Eventide to our readers with an overview of the firm?